FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/066075 [Registered on: 22/04/2024] Trial Registered Prospectively
Last Modified On: 17/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A LOCAL APPLICATION OF HARITAKI AND SHUNTHI CHURNA LEPA IN ITCHING OF EYES 
Scientific Title of Study   A RANDOMIZED CONTROLLED CLINICAL TRIAL OF HARITAKI AND SHUNTHI CHURNA BIDALAK IN VERNAL KERATO CONJUNCTIVITIS  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sneha Dnyaneshwar Moholkar  
Designation  PG Scholar  
Affiliation  Bharati Vidyapeeth (Deemed to be University) College of Ayurved, Pune  
Address  Bharati Vidyapeeth (Deemed to be University) College of Ayurved, Department of Shalakya Tantra, Katraj, Dhanakawadi Campus,Pune.
Bharati Vidyapeeth (Deemed to be University) College of Ayurved, Department of Shalakya Tantra,Katraj, Dhanakawadi Campus, Pune
Pune
MAHARASHTRA
411043
India 
Phone  8379909800  
Fax    
Email  sneha.moholkar-ayurved@bvp.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sarita Mulik 
Designation  Associate professor  
Affiliation  Bharati Vidyapeeth (Deemed to be University) College of Ayurved, Pune  
Address  Bharati Vidyapeeth (Deemed to be University) College of Ayurved, Department of Shalakya Tantra, Katraj, Dhanakawadi Campus,Pune.
Bharati Vidyapeeth (Deemed to be University) College of Ayurved, Department of Shalakya Tantra, Katraj, Dhanakawadi Campus,Pune.
Pune
MAHARASHTRA
411043
India 
Phone  9175382645  
Fax    
Email  sarita.mulik@bharatividyapeeth.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Sarita Mulik 
Designation  Associate professor  
Affiliation  Bharati Vidyapeeth (Deemed to be University) College of Ayurved, Pune  
Address  Bharati Vidyapeeth (Deemed to be University) College of Ayurved, Department of Shalakya Tantra, Katraj, Dhanakawadi Campus,Pune.
Bharati Vidyapeeth (Deemed to be University) College of Ayurved, Department of Shalakya Tantra, Katraj, Dhanakawadi Campus,Pune.
Pune
MAHARASHTRA
411043
India 
Phone  9175382645  
Fax    
Email  sarita.mulik@bharatividyapeeth.edu.in  
 
Source of Monetary or Material Support  
Bharati Vidyapeeth (Deemed to be University ) College of Ayurved and hospital Pune - satara road Pune -43 
 
Primary Sponsor  
Name  DR SNEHA MOHOLKAR  
Address  DEPARTMENT OF SHALAKYA TANTRA, COLLEGE OF AYURVED, BHARATI VIDYAPEETH (Deemed to be University),KATRAJ DHANKAWADI CAMPUS PUNE- SATARA ROAD,PUNE 
Type of Sponsor  Other [Other ( SELF)] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sneha Moholkar   BHARATI VIDYAPEETH (DEEMED TO BE UNIVERSITY) College of Ayurved And Hospital   Bharti Vidyapeeth (Deemed to be University) College of Ayurved And hospital DEPARTMENT OF SHALAKYA
Pune
MAHARASHTRA 
8379909800

sneha.moholkar-ayurved@bvp.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
BV(DU)COA-Ethics committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H108||Other conjunctivitis. Ayurveda Condition: Abhishyand, (2) ICD-10 Condition:H108||Other conjunctivitis. Ayurveda Condition: KAPABISHYANDAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure- (Procedure Reference: , Procedure details: )
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  20.00 Year(s)
Gender  Both 
Details  Patient suffering from VERNAL KERATO CONJUNCTIVITIS  
 
ExclusionCriteria 
Details  Existing occular surface pathology
One eyed patients
Post operative patients  
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The primary end point of study will be patient relieved from VERNAL KERATO CONJUNCTIVITIS without any complications   The primary end point of study will be patient relieved from VERNAL KERATO CONJUNCTIVITIS without any complications  
 
Secondary Outcome  
Outcome  TimePoints 
It is expected to equal or improved by 10% in parameters like itching burning sensation redness photophobia lacrimation   Baseline 3rd and 5th day  
 
Target Sample Size   Total Sample Size="56"
Sample Size from India="28" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   30/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  30/04/2024 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   VERNAL KERATO CONJUNCTIVITIS is a type of allergic conjunctivitis.It is bilateral, recurrent occurs mainly in the childhood from 4-20 yrs of age.Occular allergy involves the surface of all ocular components.vernal KERATO conjunctivitis is common troublesome allergic conjunctivitis affecting mainly children and adolescent with seasonal recurrence. 
Close